MARC Record from Library of Congress

LEADER: 03276cam a22003857a 4500
001 2012949069
003 DLC
005 20130126083236.0
008 120910s2012 gw a b 101 0 eng d
010 $a 2012949069
016 7 $a1023292114$2DE-101
020 $a9783642316289 (alk. paper)
020 $a364231628X (alk. paper)
020 $a9783642316296 (ebk.)
035 $a(OCoLC)ocn819379378
040 $aOHX$cOHX$dPAU$dOCLCO$dMMU$dCDX$dDLC
042 $alccopycat
050 00 $aRC280.D5$bE275 2012
050 14 $aRC261$b.R35 v.196 2012
072 7 $aRC$2lcco
082 00 $a616.99/433$223
245 00 $aEarly gastrointestinal cancers /$cFlorian Otto, Manfred P. Lutz, editors.
260 $aHeidelberg ;$aNew York :$bSpringer,$cc2012.
300 $axi, 318 p. :$bill. (some col.) ;$c24 cm.
490 1 $aRecent results in cancer research ;$v196
500 $a"Contains the majority of the invited expert contributions from the First St. Gallen EORTC Gastrointestinal Cancer Conference, held on 22-24 March 2012 in St. Gallen, Switzerland."--p. [4] of cover.
504 $aIncludes bibliographical references.
505 0 $aMultimodal approach to colorectal cancer -- Clinically relevant study end points in rectal cancer -- Neoadjuvant treatment in rectal cancer: do we always need radiotherapy or can we risk locally advanced rectal cancer better? -- Treatment dilemmas in patients with synchronous colorectal liver metastases -- Improving treatment of pancreatic cancer -- Pancreatic surgery: beyond the traditional limits -- Adjuvant therapy for pancreatic cancer -- Radiotherapy of the pancreas: state of the art in 2012 -- Different cancer types in the oesophagus and stomach -- Adenocarcinoma of the GEJ: gastric or oesophageal cancer? -- Why is there a change in patterns of GE cancer? -- Choosing the best treatment for oesophageal cancer -- Endoscopic treatment for esophageal squamous cell carcinoma -- Open or minimally invasive resection for oesophageal cancer? -- Choosing the best treatment for esophageal cancer -- Multimodal therapy of GEJ cancer -- Multimodal therapy of GEJ cancer: when is the definitive radiochemotherapy the treatment of choice? -- Radiotherapy of gastroesophageal junction cancer -- Optimizing neoadjuvant chemotherapy through the use of early response evaluation by positron emission tomography -- Gastric cancer -- Optimal surgery for gastric cancer: is more always better? -- Can adjuvant chemoratiotherapy replace extended lymph node dissection in gastric cancer? -- Predicting the response to chemotherapy in gastric adenocarcinoma: who benefits from neoadjuvant chemotherapy? -- Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients -- Adjuvant chemotherapy: an option for Asian patients only? -- Selecting the best treatment for an individual patient.
650 0 $aGastrointestinal system$xCancer.
650 12 $aGastrointestinal Neoplasms$vCongresses.
650 22 $aTime Factors$vCongresses.
700 1 $aOtto, Florian.
700 1 $aLutz, Manfred P.
711 2 $aSt. Gallen EORTC Gastrointestinal Cancer Conference$n(1st :$d2012 :$cSaint Gale, Switzerland)
830 0 $aRecent results in cancer research ;$v196.$x0080-0015